-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Industry News] In recent years, domestic and local governments are accelerating the innovation and upgrading of the medical device industry
.
At present, under a series of favorable policies, the domestic medical device industry has ushered in a broader space for development, and at the same time has embarked on the road of accelerated upgrading
.
It is understood that many medical device companies are currently using financing to accelerate the research and development of innovative medical devices
.
For example, on August 23, Jingwei Shida Medical Technology (Suzhou) Co.
, Ltd.
(hereinafter referred to as "Jingwei Shida") announced the completion of the A+ round of financing of tens of millions of RMB
.
Founded in 2014, Jingwei Shida is a technology-based enterprise engaged in the R&D, manufacturing, and application promotion of innovative medical devices.
Tumor minimally invasive diagnosis and treatment channel technology, real-time visualization biopsy technology, tumor minimally invasive treatment technology
.
It is reported that this round of financing funds will be used for the continuous research and development, large-scale production, and clinical application promotion of confocal microendoscopy products
.
Coincidentally, it was reported on the same day that Suzhou Bingjing Intelligent Medical Technology Co.
, Ltd.
also completed an angel round of financing of 10 million yuan
.
This round of financing was led by Yuanyi Capital and followed by Yinglian Health Fund.
The funds raised will be used for the company's HD-ICE (Next Generation Intracardiac Ultrasound) product research and development, platform construction, multidisciplinary talent recruitment and future capacity expansion
.
According to the data, Ice Crystal Intelligence was established in 2021, aiming at the structural heart disease and electrophysiology market, and launched the next-generation HD-ICE products with high definition and high controllability to fill the domestic gap and improve the effectiveness and safety of cardiac interventional surgery.
sex
.
In fact, in recent years, with the expansion and penetration of cardiac interventional therapy, ICE, as an intraoperative imaging tool, is facing very good development opportunities, and the market is rapidly expanding.
.
Therefore, the industry expects that Ice Crystal Intelligence will also usher in more benefits
.
In fact, the medical device track is still favored by capital this year.
In addition to the above companies, incomplete statistics show that there were 150 cumulative investment and financing events for medical devices in the first half of the year
.
The average single transaction amount was 99 million yuan, an increase of 19% over last year
.
In this regard, the industry believes that this is mainly due to the rapid development of the domestic medical device industry in recent years with the strong downstream demand, the acceleration of domestic substitution, and the continuous expansion of the market scale
.
Of course, favorable policies are also a major reason.
It is understood that the current policy side continues to support the innovation and development of the medical device industry
.
On August 19, a teleconference for the responsible comrades of the national industrial and information technology departments was held in Beijing
.
The purpose of this meeting is to fully grasp the implementation of various key tasks in the next stage, and strive to promote the implementation of policies and measures to stabilize industrial economic growth
.
Among them, the meeting emphasized that it is necessary to increase the development of emerging industries, formulate and introduce policies to promote innovation and development of industries such as energy electronics and high-end medical devices, and accelerate the development and growth of industries such as big data, cloud computing, artificial intelligence, robotics, and green environmental protection
.
The industry expects that under multiple favorable conditions, China's medical device industry will usher in a golden period of development, and the innovation and upgrading of the medical device industry will continue to accelerate
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
At present, under a series of favorable policies, the domestic medical device industry has ushered in a broader space for development, and at the same time has embarked on the road of accelerated upgrading
.
It is understood that many medical device companies are currently using financing to accelerate the research and development of innovative medical devices
.
For example, on August 23, Jingwei Shida Medical Technology (Suzhou) Co.
, Ltd.
(hereinafter referred to as "Jingwei Shida") announced the completion of the A+ round of financing of tens of millions of RMB
.
Founded in 2014, Jingwei Shida is a technology-based enterprise engaged in the R&D, manufacturing, and application promotion of innovative medical devices.
Tumor minimally invasive diagnosis and treatment channel technology, real-time visualization biopsy technology, tumor minimally invasive treatment technology
.
It is reported that this round of financing funds will be used for the continuous research and development, large-scale production, and clinical application promotion of confocal microendoscopy products
.
Coincidentally, it was reported on the same day that Suzhou Bingjing Intelligent Medical Technology Co.
, Ltd.
also completed an angel round of financing of 10 million yuan
.
This round of financing was led by Yuanyi Capital and followed by Yinglian Health Fund.
The funds raised will be used for the company's HD-ICE (Next Generation Intracardiac Ultrasound) product research and development, platform construction, multidisciplinary talent recruitment and future capacity expansion
.
According to the data, Ice Crystal Intelligence was established in 2021, aiming at the structural heart disease and electrophysiology market, and launched the next-generation HD-ICE products with high definition and high controllability to fill the domestic gap and improve the effectiveness and safety of cardiac interventional surgery.
sex
.
In fact, in recent years, with the expansion and penetration of cardiac interventional therapy, ICE, as an intraoperative imaging tool, is facing very good development opportunities, and the market is rapidly expanding.
.
Therefore, the industry expects that Ice Crystal Intelligence will also usher in more benefits
.
In fact, the medical device track is still favored by capital this year.
In addition to the above companies, incomplete statistics show that there were 150 cumulative investment and financing events for medical devices in the first half of the year
.
The average single transaction amount was 99 million yuan, an increase of 19% over last year
.
In this regard, the industry believes that this is mainly due to the rapid development of the domestic medical device industry in recent years with the strong downstream demand, the acceleration of domestic substitution, and the continuous expansion of the market scale
.
Of course, favorable policies are also a major reason.
It is understood that the current policy side continues to support the innovation and development of the medical device industry
.
On August 19, a teleconference for the responsible comrades of the national industrial and information technology departments was held in Beijing
.
The purpose of this meeting is to fully grasp the implementation of various key tasks in the next stage, and strive to promote the implementation of policies and measures to stabilize industrial economic growth
.
Among them, the meeting emphasized that it is necessary to increase the development of emerging industries, formulate and introduce policies to promote innovation and development of industries such as energy electronics and high-end medical devices, and accelerate the development and growth of industries such as big data, cloud computing, artificial intelligence, robotics, and green environmental protection
.
The industry expects that under multiple favorable conditions, China's medical device industry will usher in a golden period of development, and the innovation and upgrading of the medical device industry will continue to accelerate
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
